Casa
resultado lavoisier pcr

Identification of a novel peptide ligand for the cancer-specific receptor mutation EGFRvIII using high-throughput sequencing of phage-selected peptides

Por um escritor misterioso

Descrição
Identification of a novel peptide ligand for the cancer-specific receptor mutation EGFRvIII using high-throughput sequencing of phage-selected peptides
EGFRvIII/CD3 tandem diabody (TandAb) does not facilitate activation of
Identification of a novel peptide ligand for the cancer-specific receptor mutation EGFRvIII using high-throughput sequencing of phage-selected peptides
Design, production, and purification of recombinant EGFRvIII-targeting
Identification of a novel peptide ligand for the cancer-specific receptor mutation EGFRvIII using high-throughput sequencing of phage-selected peptides
Cancers, Free Full-Text
Identification of a novel peptide ligand for the cancer-specific receptor mutation EGFRvIII using high-throughput sequencing of phage-selected peptides
Frontiers PDL1Binder: Identifying programmed cell death ligand 1 binding peptides by incorporating next-generation phage display data and different peptide descriptors
Identification of a novel peptide ligand for the cancer-specific receptor mutation EGFRvIII using high-throughput sequencing of phage-selected peptides
Pharmaceutics, Free Full-Text
Identification of a novel peptide ligand for the cancer-specific receptor mutation EGFRvIII using high-throughput sequencing of phage-selected peptides
Novel EGFR-targeted strategy with hybrid peptide against oesophageal squamous cell carcinoma
Identification of a novel peptide ligand for the cancer-specific receptor mutation EGFRvIII using high-throughput sequencing of phage-selected peptides
The screening, identification, design and clinical application of tumor- specific neoantigens for TCR-T cells, Molecular Cancer
Identification of a novel peptide ligand for the cancer-specific receptor mutation EGFRvIII using high-throughput sequencing of phage-selected peptides
Fingerprinting the circulating repertoire of antibodies from cancer patients
Identification of a novel peptide ligand for the cancer-specific receptor mutation EGFRvIII using high-throughput sequencing of phage-selected peptides
PDF) Identification of Novel Peptide Ligands for the Cancer-Specific Receptor Mutation EFGRvIII Using a Mixture-Based Synthetic Combinatorial Library
de por adulto (o preço varia de acordo com o tamanho do grupo)